Press Release

Ballard Spahr Launches COVID-19 State and Federal Legislation Trackers

Issued by Ballard Spahr LLP

Mar. 24, 2020

PHILADELPHIA (March 23, 2020) – To help clients track breaking developments during the coronavirus pandemic, the Client Value and Innovation Team at Ballard Spahr has created two online legislative tracking tools — one for state legislation and one for federal.

The tools provide comprehensive, up-to-date information on all proposed and enacted legislation and executive orders related to coronavirus. They include data on the type of legislation being enacted, the status of bills, and summaries of their content.  

The trackers are offered as part of the firm’s Coronavirus Disease 2019 (COVID-19) Resource Center, an online hub that offers information and guidance on how to address the legal questions posed by the worldwide spread of the virus.

The state legislative tracker is available here.

The federal legislative tracker is available here.

About Ballard Spahr
Ballard Spahr LLP, an AmLaw 100 law firm with more than 650 lawyers in 15 U.S. offices, serves clients across industry sectors in litigation, transactions, and regulatory compliance. We partner with clients — from start-ups to Fortune 500 companies, governments, and non-profit organizations — to deliver the strategic counsel, powerful advocacy, and dynamic thinking that helps them overcome challenges, protect what’s important, and position themselves for future success. The firm combines a comprehensive scope of practice with strong regional market knowledge. And we are nationally recognized in the development and use of innovative technology to drive efficiency, transparency, and results. Please visit www.ballardspahr.com.

BL:hh

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.